International Journal of Translational Research

International Journal of Translational Research

International Journal of Translational Research – Membership

Open Access & Peer-Reviewed

Submit Manuscript
Open Access | Peer-Reviewed
Translational Medicine → Clinical Impact
International Journal of Translational Research

Membership Program

Accelerating the transformation of scientific discoveries into clinical applications through collaborative publishing partnerships.

Basic Research

From Laboratory Discovery

Genomics, proteomics, molecular biology, biomarker identification, preclinical studies, and fundamental mechanistic research that advances our understanding of human disease.

Translational Bridge

Clinical Application

To Patient Outcomes

Drug development, clinical trials, therapeutic interventions, diagnostic tools, personalized medicine, and evidence-based treatments that improve patient care.

The International Journal of Translational Research provides a distinguished platform for investigators bridging fundamental scientific discoveries with clinical applications. Our membership program supports researchers, clinicians, and institutions committed to accelerating the bench-to-bedside pipeline through rigorous peer-reviewed publication of high-impact translational studies.

IJTR welcomes submissions spanning the entire translational research continuum—from molecular mechanisms, genomics, and biomarker discovery to clinical trial outcomes, therapeutic development, and healthcare implementation strategies. Our distinguished editorial board comprises translational medicine specialists who evaluate manuscripts for scientific rigor, methodological soundness, clinical relevance, and potential for meaningful real-world impact on patient care and medical practice advancement.

Whether you are conducting preclinical mechanistic studies, developing novel therapeutic approaches, or reporting clinical trial outcomes that inform treatment guidelines, IJTR membership provides the publishing support your translational research program requires.

01

Unlimited Submissions

Submit unlimited original research, clinical studies, and translational case reports throughout your membership period with complete APC coverage.

02

Expert Translational Review

Manuscripts evaluated by specialists in translational medicine who understand both basic science methodology and clinical research standards.

03

Global Open Access

Your research reaches clinicians, scientists, and policymakers worldwide through unrestricted open-access distribution without subscription barriers.

04

Professional Recognition

Receive official IJTR membership certification acknowledging your contribution to advancing translational science and clinical implementation.

Individual Researcher Membership

Basic Science

Designed for investigators, clinician-scientists, and academic researchers conducting translational studies. Includes unlimited submissions with full APC waivers for regular issues and 30% discount on special issue contributions.

Duration Standard APC Value Member Investment
1 Year $5,400 $2,970
2 Years $6,300 $3,465

Trainee Membership

Clinical Training

Supporting doctoral candidates, postdoctoral fellows, and clinical residents building translational research portfolios. Requires program director recommendation confirming active enrollment in an accredited research training program.

Duration Standard Rate Trainee Rate
1 Year $3,200 $2,080
2 Years $3,700 $2,405

Institutional Partnership

Research Centers

Academic medical centers, translational research institutes, and university departments benefit from comprehensive agreements covering all affiliated investigators, postdocs, and research faculty engaged in translational studies.

Duration Investment Manuscripts Per Article Cost
1 Year $9,500 20 manuscripts $475
2 Years $11,500 30 manuscripts $383

Industry & Pharma Partnership

Drug Development

Pharmaceutical companies, biotechnology firms, and medical device organizations gain credibility through peer-reviewed publication of preclinical data, clinical trial results, and translational development studies.

Tier Publications Standard Partner Rate
Silver 10 per year $5,600 $3,640
Gold 15 per year $6,500 $4,225

Translational Research Areas

Genomics & Proteomics Personalized Medicine Drug Discovery Clinical Trials Biomarker Development Gene Therapy Pharmacogenomics Medical Devices Cancer Therapeutics Immunotherapy

Frequently Asked Questions

What distinguishes translational research submissions?
IJTR evaluates submissions for their potential to bridge basic science and clinical application. We prioritize studies that demonstrate clear pathways from laboratory findings to therapeutic development, diagnostic innovation, or clinical implementation strategies.
Are clinical trial reports within scope?
Yes. IJTR welcomes Phase I-IV clinical trial reports, particularly those demonstrating translation of preclinical findings. We also publish correlative studies that inform mechanism of action and patient selection for targeted therapies.
How does institutional membership benefit research departments?
Institutional partnerships cover all department members—faculty, postdocs, and research staff—under a single agreement. This simplifies grant budgeting for publication costs and encourages collaborative translational publications across investigator teams.
Can pharmaceutical sponsors publish industry-sponsored research?
Industry-sponsored translational research undergoes the same rigorous peer review as academic submissions. Corporate partnership membership provides discounted publication fees while maintaining complete editorial independence and scientific integrity.
What renewal benefits are available for continuing members?
Members who renew before expiration receive a 10% loyalty discount and may transfer unused publication credits to the new term. This flexibility accommodates typical translational research timelines including regulatory approval and clinical enrollment periods.
Does IJTR accept AI-enhanced research methodologies?
Yes. IJTR encourages submissions leveraging artificial intelligence for biomarker discovery, patient stratification, drug response prediction, and clinical decision support. We request transparent reporting of AI methodologies and validation approaches in accordance with emerging reporting standards.
What data sharing requirements apply to published articles?
IJTR promotes open science principles. Authors are encouraged to deposit datasets in appropriate repositories and provide code availability statements. For clinical research, data sharing should comply with patient privacy regulations and institutional requirements.

Membership Terms & Conditions

Eligibility Requirements: To qualify for membership benefits including Article Processing Charge waivers, the member must be listed as author or corresponding author on submitted manuscripts. Trainee membership requires written recommendation from program leadership confirming enrollment in an accredited doctoral, postdoctoral, or clinical research training program.

Membership Certification: All registered members receive an official IJTR Membership Certificate recognizing their contributions to translational science and commitment to accelerating the bench-to-bedside research pipeline through open-access publication.

Submission Coverage: Unlimited manuscript submissions are covered for regular journal issues. Members receive a 30% discount on Article Processing Charges for virtual special issues focusing on specific therapeutic areas, emerging technologies, or translational methodologies.

Renewal Policy: Early renewal before expiration qualifies for a 10% discount and unused benefit transfer. Renewals submitted after expiration are processed at standard rates without continuation of unused entitlements. We recommend advance renewal planning to maintain uninterrupted membership benefits.

Special Issue Participation: IJTR periodically publishes virtual special issues on emerging therapeutic areas, novel technologies, and translational methodologies. Members receive priority consideration for special issue contributions and reduced APC rates for accepted manuscripts.

Important Notice: All benefits must be utilized within the designated membership validity period. Unused entitlements expire at membership term conclusion unless early renewal is completed. Contact our membership team with questions regarding benefit utilization or institutional upgrade pathways.

Advance Translational Science

Contact our membership team to discuss the optimal partnership tier for your translational research program. We assess publication volume, institutional requirements, and research focus to recommend appropriate membership options.

Apply for Membership View APC Details

Email: [email protected] | Response within 24 business hours